港股異動丨易點雲大升超30% 與信諾時代訂立戰略合作協議
易點雲(2416.HK)盤初拉昇升超30%報5.5港元,為連續第三日上升。根據公吿,該公司在2024年2月22日與北京信諾時代科技發展有限公司(信諾時代)訂立戰略合作協議,其中易點雲和信諾時代將充分依託其各自技術與資源優勢,就信諾時代獲授權經銷的微軟Azure OpenAI產品矩陣和解決方案的市場擴展形成全面戰略合作,包括但不限於在GPT相關產品以及未來微軟Azure雲上將發佈的AI產品和服務方面的合作。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.